ACCESS Newswire
Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package
📈
AI Sentiment
Highly Positive
8/10
- Home
- TIVC
as of 12-17-2025 3:58pm EST
$1.91
$0.09
-4.50%
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
Chart Type:
Time Range:
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | FREMONT |
| Market Cap: | 3.6M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 66.8K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -9.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.47 - $15.64 | Next Earning Date: | 11-14-2025 |
| Revenue: | $482,000 | Revenue Growth: | -49.63% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Tivic Health Systems Inc. News
TIVC Breaking Stock News: Dive into TIVC Ticker-Specific Updates for Smart Investing
Compare TIVC vs Leading Stocks
See how TIVC stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "TIVC Tivic Health Systems Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.